Mottet N et al. [5] showed that PSA screening alone detected more low-risk PC patients but had no significant effect on PC mortality (median follow-up of 10 years), indicating that these patients may have received unnecessary treatment. The gene discussed is KLK3; the disease is pachyonychia congenita.